Stock of the Day

January 10, 2024

GE HealthCare Technologies (GEHC)

$63.07
-$2.63 (-4.0%)
Market Cap: $29.89B

About GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GE HealthCare Technologies Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • The current stock price is around $63, which is significantly lower than its 1-year high, indicating potential for growth.
  • The company reported a quarterly revenue increase of 7.4% year-over-year, showcasing strong demand for its medical technology products.
  • GE HealthCare Technologies Inc. has a solid return on equity of 20.46%, reflecting effective management and profitability.
  • The firm has a low debt-to-equity ratio of 0.95, suggesting a balanced approach to leveraging debt for growth while maintaining financial stability.
  • With a P/E ratio of 15.62, the stock may be considered undervalued compared to industry peers, presenting a buying opportunity for investors.

GE HealthCare Technologies Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • The company recently missed earnings expectations, reporting $0.99 EPS compared to the consensus estimate of $1.07, which may raise concerns about future performance.
  • GE HealthCare Technologies Inc. has a relatively low dividend yield of 0.2%, which may not attract income-focused investors.
  • The stock has a beta of 0.72, indicating lower volatility compared to the market, which may limit potential high returns for aggressive investors.
  • Despite revenue growth, the net margin of 9.10% suggests that profitability could be impacted by rising costs or competition in the healthcare sector.
  • The company's PEG ratio of 1.76 indicates that the stock may be overvalued relative to its earnings growth rate, which could deter value investors.
← Previous Stock of the DayNext Stock of the Day →

Recent News